# OnCo record ravindra-uppaluri (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ravindra-uppaluri/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ravindra-uppaluri" ;
  schema:name "Ravindra Uppaluri"@en ;
  schema:description "Surgeon-scientist who led the first neoadjuvant pembrolizumab trial in head and neck cancer and the KEYNOTE-689 study that made it standard."@en ;
  schema:url <https://onco.cc/people/ravindra-uppaluri/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Uppaluri%20R%5BAuthor%5D%20neoadjuvant%20pembrolizumab%20head%20neck> ;
  onco:tag "head-and-neck", "surgery", "neoadjuvant" ;
  schema:jobTitle "Chief of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute" ;
  schema:sameAs <https://orcid.org/0000-0001-5988-6828> ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> ;
  onco:trials <https://onco.cc/trials/keynote-689/> ;
  schema:affiliation <https://onco.cc/institutions/dana-farber/> .